Here are 10 report highlights:
1. In Q4 2016, NuVasive’s revenue totaled $271.1 million, reflecting a 25.9 percent boost from the same period the year prior.
2. NuVasive’s gross profit totaled $204.2 million in Q4 2016, on a GAAP and non-GAAP basis.
3. The company’s GAAP operating profit margin was 11.1 percent in Q4 2016, with a non-GAAP operating profit margin of 18 percent.
4. NuVasive witnessed GAAP diluted earnings per share of $0.11, and non-GAAP diluted earnings per share of $0.53.
5. NuVasive saw revenue of $962.1 million for the full year of 2016, an 18.6 percent increase from full-year 2015.
6. The company’s GAAP gross profit totaled $722 million and non-GAAP gross profit was $736.7 million for the full-year 2016.
7. The full-year 2016 GAAP operating profit margin was 12.8 percent, with a non-GAAP operating profit margin of 16.1 percent.
8. The company saw GAAP diluted earnings per share of $0.69 for the full-year 2016, and non-GAAP diluted earnings per share of $1.66.
9. NuVasive’s cash, cash equivalents and short and long-term marketable securities totaled about $153.6 million by Dec. 31, 2016.
10. In 2017, the company will look to expand its spine deformity presence, boost in-sourced manufacturing and streamline operations.
“NuVasive delivered record fourth quarter results and exceeded expectations for the full year 2016. By all measures, the company had a tremendous year executing against our market-share taking initiatives, delivering strong revenue growth, including a return to 20% year-over-year growth in our core international markets,” said Gregory T. Lucier, chairman and CEO of NuVasive.
More articles on devices:
ReMAP cleared to market 7D — 5 details
Medacta acquires Vivamed: 5 key notes
FDA reclassifies pedicle screws & clarifies dynamic stabilization systems
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
